Ovarian Cancer Canada

Western Regional Blog – BC, YK, AB, NWT and Nunavut

Celebrities and Health: Good, Bad, and Ugly – in the BMJ

“The first step to addressing celebrity medicine is recognizing that it is a human vulnerability and a serious public health challenge. Doing that can empower us to think twice before we … Continue reading

January 16, 2014

Oncofertility Referral Network

https://cancerkn.com/oncofertility-referral-network/ Oncofertility is an interdisciplinary approach to address the reproductive future of young men, women, and children facing a life-preserving but fertility threatening cancer diagnosis. The CKN Oncofertility Referral Network is a … Continue reading

January 16, 2014

Missing a Cancer Diagnosis

By Susan Gubar http://well.blogs.nytimes.com/2014/01/02/missing-a-cancer-diagnosis/nl=health&emc=edit_hh_20140107&_r=0 Stories of misdiagnoses circulate throughout the testimonies of people contending with all sorts of cancers. Such errors, made by patients as well as doctors, bring in their … Continue reading

January 16, 2014

The Must-Have Binder: My Key to Being an Organized Patient (or Caregiver)

By Lisa Bonchek Adams, Cancer Survivor https://cancerkn.com/the-must-have-binder-my-key-to-being-an-organized-patient-or-caregiver/

January 16, 2014

Conservative Treatment of Early Stage Ovarian Cancer: Oncological and Fertility Outcomes

The authors review the current data surrounding management strategies for younger women of child-bearing potential who wish to pursue fertility-sparing treatment for early-stage ovarian cancer. –

January 16, 2014

Risk Management Options Elected by Women Testing BRCA-Positive

*Although 75% of women with BRCA1/2 mutations underwent risk-reducing salpingo-oophorectomy during follow-up, only 17% underwent the procedure prior to the NCCN recommended age of 40 years.

January 16, 2014

Researchers Discover Ovarian Cancer Biomarker

“To determine patient response, her team analyzed 80 human tumor samples and used a combination of in vitro and preclinical ovarian mouse models (human tumor cells injected in a mouse) to … Continue reading

January 16, 2014

New Task Force Recommendations for BRCA Mutation Screening

“BRCA mutation testing should only be done for those patients who have either a personal or family history that suggests a role of inherited cancer susceptibility. Testing for these mutations are … Continue reading

January 16, 2014

Precision Oncology

“I’m very confident that, in the future, we will actually be able to develop therapies, either single therapies or, more likely, combinations of therapies that target multiple weak links within these pathways … Continue reading

January 16, 2014

Complementary and Alternative Therapies

CAMEO

Research in BC

The Injustices of Ovarian Cancer

Ovarian Cancer Canada